{
    "clinical_study": {
        "@rank": "129402", 
        "brief_summary": {
            "textblock": "To investigate the prognosis due to presence or absence of bile duct resection in\n      intrahepatic cholangiocarcinoma that require hepatic lobectomy."
        }, 
        "brief_title": "Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Intrahepatic Cholangiocarcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Cholangiocarcinoma", 
                "Liver Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type,\n      is still controversial.  We retrospectively evaluated the effect of bile duct resection in\n      this surgery."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Cases of major hepatectomy due to intrahepatic cholangiocarcinoma\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients who underwent hepatic lobectomy between 2000 and 2010 for intrahepatic\n        cholangiocarcinoma, and did not undergo adjuvant chemotherapy will be included for\n        analysis."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01862276", 
            "org_study_id": "KHBO1206", 
            "secondary_id": "UMIN000010416"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Osaka", 
                    "country": "Japan", 
                    "zip": "565-0871"
                }, 
                "name": "Osaka University, Graduate School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma", 
        "overall_official": {
            "affiliation": "Osaka University, Graduate School of Medicine", 
            "last_name": "Hiroaki Nagano, MD, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Japan: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "3-year recurrence-free survival rate", 
                "safety_issue": "No", 
                "time_frame": "11 years (2000-2010)"
            }, 
            {
                "measure": "Ratio of local recurrence at the hepatico-duodenal ligament", 
                "safety_issue": "No", 
                "time_frame": "11 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01862276"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Kansai Hepatobiliary Oncology Group", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kansai Hepatobiliary Oncology Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}